Correlation between motor impairment and infarct volume after permanent and transient middle cerebral artery occlusion in the rat

Stroke

Volumn 28, Issue 10, 1997, Pages 2060-2066

  Rogers, Derek C ^a   Campbell, Colin A ^a   Stretton, Jennifer L ^a   Mackay, Kenneth B ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Cerebral ischemia, focal; Motor activity; Rat; Reperfusion

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INFARCTION; BRAIN SIZE; FUNCTIONAL ASSESSMENT; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NONHUMAN; PRIORITY JOURNAL; RAT; STROKE; WALKING;

EID: 0030685811     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.28.10.2060     Document Type: Article

References (36)

1. Hossmann KA. Animal models of cerebral ischemia, 1: review of literature. Cerebrovasc Dis. 1991;1(suppl 1):2-15.
2. Hunter AJ, Green AR, Cross AJ, Animal models of acute ischaemic stroke: can they predict clinically successful neuroprotective drugs? Trends Pharmacol Sci. 1995;16:123-128.
3. Macrae IM. New models of focal cerebral ischaemia, Br J Clin Pharmacol. 1992;34:302-308.
4. McCauley MA. Rodent models of focal cerebral ischemia. Cerebrovasc Brain Metab Rev. 1995;7:153-180.
5. Tamura A, Graham DI, McCulloch J, Teasdale GM. Focal cerebral ischaemia in the rat, 1: description of technique and early neuropathological consequenses following middle cerebral artery occlusion. J Cereb Blood Flow Metab. 1981;1:53-60.
6. Zea Longa Z, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1980;20:84-91.
7. Tominaga T, Ohnishi ST. Interrelationship of brain edema, motor deficits, and memory impairment in rats exposed to focal ischemia. Stroke. 1989;20:513-518.
8. Markgraf CG, Green EJ, Hurwitz BE, Morikawa E, Dietrich WD, McCabe PM, Ginsberg MD, Schneiderman N. Sensorimotor and cognitive consequences of middle cerebral artery occlusion in rats. Brain Res. 1992;575:238-246.
9. Marston HM, Faber ESL, Crawford JH, Butcher SP, Sharkey J. Behavioural assessment of endothelin-1 induced middle cerebral artery occlusion in the rat. Neuroreport. 1995;6:1067-1071.
10. Okada M, Tamura A, Urae A, Nakagomi T, Kirino T, Mine K, Fujiwara M. Long-term spatial cognitive impairment following middle cerebral artery occlusion in rats: a behavioral study. J Cereb Blood Flow Metab. 1995;15:505-512.
11. van der Staay FJ, Augstein KH, Horvath E. Sensorimotor impairments in Wistar Kyoto rats with cerebral infarction, induced by unilateral occlusion of the middle cerebral artery: recovery of function. Brain Res. 1996;715:180-188.
12. Yamamoto M, Tamura A, Kirino T, Shimizu M, Sano K. Behavioral changes after focal cerebral ischemia by left middle cerebral artery occlusion in rats. Brain Res. 1988;452:323-328.
13. Aronowski J, Samways E, Strong R, Rhoades HM, Grotta JC. An alternative method for the quantification of neuronal damage after experiments middle cerebral artery occlusion in rats: analysis of behavioral deficit. J Cereb Blood Flow Metab. 1996;16:705-713.
14. Belayev L, Busto R, Zhao W, Ginsberg MD. HU-211, a novel non-competitive N-methyl-d-aspartate antagonist, improves neurological deficit and reduces infarct volume after reversible focal cerebral ischemia in the rat. Stroke. 1995;26:2313-2320.
15. Borlongan CV, Cahill, DW, Sanberg PR. Locomotor and passive avoidance deficits following occlusion of the middle cerebral artery. Physiol Behav. 1995;58:909-917.
16. Sakai N, Yanai K, Ryu JH, Nagasawa H, Hasegawa T, Sasaki T, Kogure K, Watanabe T. Behavioral studies on rats with transient cerebral ischemia induced by occlusion of the middle cerebral artery. Behav Brain Res. 1996;77:181-188.
17. Grabowski M, Brundin P, Johansson BB. Paw-reaching, sensorimotor, and rotational behavior after brain infarction in rats. Stroke. 1993;24:889-895.
18. Alexis NE, Back T, Zhao W, Dietrich WD, Watson BD, Ginsberg MD. Neurobehavioral consequences of inducing spreading depression following photothrombotic middle cerebral artery occlusion. Brain Res. 1996;706:273-282.
19. Yonemori F, Yamada H, Yamaguchi T, Uemura A, Tamura A. Spatial memory disturbance after focal cerebral ischemia in rats. J Cereb Blood Flow Metab. 1996;16:973-980.
20. Mackay KB, Bailey SB, King PD, Patel S, Hamilton TC, Campbell CA. Neuroprotective effect of recombinant neutrophil inhibitory factor in transient focal cerebral ischaemia in the rat. Neurodegeneration. 1996;5:319-323.
21. Minematsu K, Fisher M. MK-801 reduces extensive infarction after suture middle cerebral artery occlusion in rats. Cerebrovasc Dis. 1993;3:99-104.
22. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurological examination. Stroke. 1986;17:472-476.
23. Persson L, Hardemark HG, Bolander, HG, Hillered L, Olsson Y. Neurologic and neuropathologic outcome after middle cerebral artery occlusion in rats. Stroke. 1989;20:641-645.
24. Jones BJ, Roberts, DJ. The quantitative measurement of motor incoordination in naive mice using an accelerating rotarod. J Pharm Pharmacol. 1968;20:302-304.
25. Hamm RJ, Pike BR, O'Dell DM, Lyeth BG, Jenkins LW. The rotarod test: an evaluation of its effectiveness in assessing motor deficits following traumatic brain injury. J Neurotrauma. 1994;11: 187-196.
26. Hernandez TD, Schallert T. Seizures and recovery from experimental brain damage. Exp Neurol. 1988;102:318-324.
27. Osborne KA, Shigeno T, Balarsky A-M, Ford I, McCulloch J, Teasdale GM, Graham DI. Quantitative assessment of early brain damage in a rat model of focal cerebral ischaemia. J Neurol Neurosurg Psychiatry. 1987;50:402-410.
28. Garcia JH, Liu KF. Brain parenchymal responses to experimental focal ischemia: cellular inflammation. In: Krieglstein J, ed. Pharmacology of Cerebral Ischemia. Stuttgart, Germany: Medpharm Scientific Publishers; 1996:379-384.
29. Chopp M, Zhang RL, Chen H, Li Y, Jiang N, Rusche JR. Postischemic administration of an anti-Mac-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in rats. Stroke. 1994;24:869-976.
30. Jiang N, Kowaluk EA, Lee CH, Mazdiyasni H, Chopp M. Adenosine kinase inhibition protects against transient focal ischemia in rats. Eur J Pharmacol. 1997;320:131-137.
31. Barone FC, Price WJ, Willette RN, Fuerstein GZ. Genetic hypertension and increased susceptibility to cerebral ischemia. Neurosci Behav Rev. 1992;16:219-233.
32. Menzies SA, Hoff JT, Betz AL. Middle cerebral artery occlusion in rats: a neurological and pathological evaluation of a reproducible model. Neurosurgery. 1992;31:100-107.
33. Wahl F, Allix M, Plotkine M, Boulu RG. Neurological and behavioral outcomes of focal cerebral ischemia in rats. Stroke. 1992;23:267-272.
34. Kawamata T, Alexis NE, Dietrich WD, Finklestein SP. Intracisternal basic fibroblast growth factor (bFGF) enhances behavioral recovery following focal cerebral infarction in the rat. J Cereb Blood Flow Metab. 1996;16:542-547.
35. Montoya CP, Campbell-Hope LJ, Pemberton KD, Dunnett SB. The 'staircase test': a measure of independent forelimb reaching and grasping abilities in rats. J Neurosci Methods. 1991;36: 219-228.
36. Sharkey J, Crawford JH, Butcher SP, Marston HM. Tacrolimus (FK506) ameliorates skilled motor deficits produced by middle cerebral artery occlusion in rats. Stroke. 1996;27:2282-2286.